 1 Agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
 6 Agents against pathologic organisms and parasites
|
61 Antibiotics
|
611 Acting mainly on gram-positive bacteria
|
612 Acting mainly on gram-negative bacteria
|
613 Acting mainly on gram-positive and gram-negative bacteria
|
6131 Penicillins
|
6132 Cephem antibioitics
|
6133 Oxacephem antibioitics
|
6134 Amino sugars
|
6135 Fosfomycins
|
6139 Others
|
 D02065 Ampicillin sodium and sulbactam sodium (JP18)
D06485 Amoxicillin hydrate and potassium clavulanate
D02505 Tazobactam and piperacillin (JP18)
D08772 Cefoperazone sodium and sulbactam sodium (JP18)
D02222 Meropenem (USP); Meropenem hydrate (JP18)
D01836 Doripenem hydrate (JP18)
D01057 Biapenem (JAN/USAN/INN)
D09598 Tebipenem pivoxil (JAN/USAN/INN)
D00344 Imipenem and cilastatin sodium (JP18)
D02509 Panipenem and betamipron (JP18)
D01839 Faropenem sodium hydrate (JP18)
D10577 Ceftolozane sulfate and tazobactam sodium
|
614 Acting mainly on gram-positive bacteria and mycoplasma
|
615 Acting mainly on gram-positive bacteria, gram-negative bacteria, rickettsia and chlamydia
|
616 Acting mainly on acid-fast bacteria
|
617 Acting mainly on mold
|
619 Miscellaneous
|
62 Chemotherapeutics
|
63 Biological preparations
|
64 Parasitics (systemic)
|
69 Other agents against pathogenic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan